Pacific Biosciences of California (NASDAQ:PACB) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.27) EPS for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.02, RTT News reports. The company had revenue of $58.36 million for the quarter, compared to analyst estimates of $57.96 million. Pacific Biosciences […]